Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03975400 · ClinicalTrials.gov registry record · NA
Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 698
- Enrollment target
NCT03975400 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 698 participants.
The verdict
NCT03975400, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 698 participants
- Enrollment target
Study Summary
There is compelling evidence that longer duration of untreated psychosis independently predicts negative outcomes. The proposal aims to explore whether targeted and proactive online outreach through search engine advertisements, coupled with engaging, informative, and interactive online resources, can effectively reduce the duration of untreated psychosis and facilitate earlier treatment initiation in New York State. Results from this initiative will be critical to informing the subsequent design and conduct of larger, focused, and proactive digital media campaigns targeting patient with First Episode Psychosis and their caregivers online, intended to accelerate linkage to care and reduce the duration of untreated psychosis throughout the U.S.
Interventions
- BEHAVIORAL search engine advertisement campaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 698 participants |
| Start Date | 2020-04-22 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03975400
The ClinicalTrials.gov registry entry for NCT03975400 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 698 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which search engine advertisement campaign is the first listed.
NCT03975400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03975400 about?
NCT03975400 is a clinical study titled "Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis". There is compelling evidence that longer duration of untreated psychosis independently predicts negative outcomes. The proposal aims to explore whether targeted and proactive online outreach through search engine advertisements, coupled with engaging, informative, and interactive online resources, c...
What is the current status of trial NCT03975400?
This trial is currently completed. It is a NA study. The enrollment target is 698 participants. The study started on 2020-04-22. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03975400?
The interventions under investigation include: search engine advertisement campaign (BEHAVIORAL).
Who is sponsoring clinical trial NCT03975400?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.